Abstract
Venomous glands of cone snails, scorpions, and so on contain many peptide neurotoxins. They mostly act on ion channels and neurotransmitter receptors with high specificity and are promising tools for developing novel peptide drugs. For this purpose, structure-function relationship of the peptides should be studied in detail. In this chapter, the relationships will be described for several peptide neurotoxins studied in the author’s laboratory such as conotoxins from cone snails and hefutoxins from scorpions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Akondi KB, Muttenthaler M, Dutertre S, Kaas Q, Craik DJ, Lewis RJ, et al. Discovery, synthesis, and structure-activity relationships of conotoxins. Chem Rev. 2014;114:5815–47.
Balaji RA, Ohtake A, Sato K, Gopalakrishnakone P, Kini RM, Tong S-K, et al. λ-conotoxins, a new family of conotoxins with unusual disulfide pattern and protein folding: isolation and characterization from the venom of Conus marmoreus. J Biol Chem. 2000;275:39516–22.
Barhanin J, Hugues M, Schweitz H, Vincent J-P, Lazdunski M. Structure-function relationships of sea anemone toxin II from Anemonia sulcata. J Biol Chem. 1981;256:5764–9.
Basus VJ, Nadasdi L, Ramachandran J, Miljanich GP. Solution structure of ω-conotoxin MVIIA using 2D NMR spectroscopy. FEBS Lett. 1995;370:163–9.
Becker S, Atherton E, Gordon RD. Synthesis and characterization of μ-conotoxin IIIa. Eur J Biochem. 1989;185:79–84.
Becker S, Prusak-Sochaczewski E, Zamponi G, Beck-Sickinger AG, Gordon RD, French RJ. Action of derivatives of μ-conotoxin GIIIA on sodium channels. Single amino acid substitution in the toxin separately affect association and dissociation rates. Biochemistry. 1992;31:8229–38.
Bergeron ZL, Bingham J-P. Scorpion toxins specific for potassium (K+) channels: a historical overview of peptide bioengineering. Toxins. 2012;4:1082–119.
Catterall WA. Structure and function of voltage-sensitive ion channels. Science. 1988;242:50–61.
Catterall WA, Swanson TM. Structural basis for pharmacology of voltage-gated sodium and calcium channels. Mol Pharmacol. Published on April 6, 2015 as doi:10.1124/mol.114.097659.
Chahine M, Chen L-Q, Fotouchi N, Walsky R, Fry D, Santarelli V, et al. Characterizing the μ-conotoxin binding site on voltage-sensitive sodium channels with toxin analogs and channel mutations. Recept Channels. 1995;3:161–74.
Chang NS, French RJ, Lipkind GM, Fozzard HA, Dudley Jr S. Predominant interactions between μ-conotoxin Arg-13 and the skeletal muscle Na+ channel localized by mutant cycle analysis. Biochemistry. 1998;37:4407–19.
Cruz LJ, Gray WR, Olivera BM, Zeikus RD, Kerr L, Yoshikami D, et al. Conus geographus toxins that discriminate between neuronal and muscle sodium channels. J Biol Chem. 1985;260:9280–8.
Cruz LJ, Kupryszewski G, LeCheminant GW, Gray WR, Olivera BM, Rivier J. μ-conotoxin GIIIA, a peptide ligand for muscle sodium channels: chemical synthesis, radiolabeling, and receptor characterization. Biochemistry. 1989;28:3437–42.
Davis JH, Bradley EK, Miljanich GP, Nadasdi L, Ramachandran J, Basus VJ. Solution structure of ω-conotoxin GVIA using 2-D NMR spectroscopy and relaxation matrix analysis. Biochemistry. 1993;32:7396–405.
El-Hayek R, Lokuta AJ, Arevalo C, Valdivia HH. Peptide probe of ryanodine receptor function. J Biol Chem. 1995;270:28696–704.
Fainzilber M, Lodder JC, van der Schors RC, Li KW, Yu Z, Burlingame AL, et al. A novel hydrophobic ω-conotoxin blocks molluscan dihydropyridine-sensitive calcium channels. Biochemistry. 1996;35:8748–52.
Farr-Jones S, Miljanich GP, Nadasdi L, Ramachandran J, Basus VJ. Solution structure of ω-conotoxin MVIIC, a high affinity ligand of P-type calcium channels, using 1H NMR spectroscopy and complete relaxation matrix analysis. J Mol Biol. 1995;248:106–24.
Flinn JP, Pallaghy PK, Lew MJ, Murphy R, Angus JA, Norton RS. Roles of key functional groups in ω-conotoxin GVIA synthesis, structure and functional assay of selected peptide analogues. Eur J Biochem. 1999a;262:447–55.
Flinn JP, Pallaghy PK, Lew MJ, Murphy R, Angus JA, Norton RS. Role of disulfide bridges in the folding, structure and biological activity of ω-conotoxin GVIA. Biochim Biophys Acta. 1999b;1434:177–90.
Gray WR, Olivera BM, Cruz LJ. Peptide toxins from venomous Conus snails. Annu Rev Biochem. 1988;57:665–700.
Grizel AV, Glukhov GS, Sokolova OS. Mechanisms of activation of voltage-gated potassium channels. Acta naturae. 2014;6:10–26.
Hasson A, Fainzilber M, Gordon D, Zlotkin E, Spira M. Alteration of sodium currents by new peptide toxins from the venom of a molluscivorous Conus snail. Eur J Neurosci. 1993;5:56–64.
Hidaka Y, Sato K, Nakamura H, Ohizumi Y, Kobayashi J, Shimonishi Y. Disulfide pairings in geographutoxin I, a peptide neurotoxin from Conus geographus. FEBS Lett. 1990;264:29–32.
Hillyard DR, Olivera BM, Woodward S, Corpuz GP, Gray WR, Ramilo CA, et al. A molluskivorous Conus toxin: conserved frameworks in conotoxins. Biochemistry. 1989;28:358–61.
Hillyard DR, Monje VD, Mintz IM, Bean BP, Nadasdi L, Ramachandran J, et al. A new conus peptide ligand for mammalian presynaptic Ca2+ channels. Neuron. 1992;9:69–77.
Kim J-I, Takahashi M, Ogura A, Kohno T, Kudo Y, Sato K. Hydroxyl group of Tyr13 is essential for the activity of ω-conotoxin GVIA, a peptide toxin for N-type calcium channel. J Biol Chem. 1994;269:23876–8.
Kim J-I, Takahashi M, Ohtake A, Wakamiya A, Sato K. Tyr13 is essential for the activity of ω-conotoxin MVIIA and GVIA, specific N-type calcium channel blockers. Biochem Biophys Res Commun. 1995a;206:449–54.
Kim J-I, Takahashi M, Martin-Moutot N, Seagar MJ, Ohtake A, Sato K. Tyr13 is essential for the binding of ω-conotoxin MVIIC to the P/Q-type calcium channel. Biochem Biophys Res Commun. 1995b;214:305–9.
Kim J-I, Takahashi M, Ogura A, Kohno T, Kudo Y, Sato K. Hydrogen bonds are essential for the folding and biological activities of ω-conotoxin, a specific blocker of the N-type calcium channel. In: Maia HL, editor. Peptides 1994. Leiden: ESCOM Science Publishers B.V; 1995c.
Kobayashi K, Sasaki T, Sato K, Kohno T. Three-dimensional solution structure of ω-conotoxin TxVII, an L-type calcium channel blocker. Biochemistry. 2000;39:14761–7.
Kohno T, Kim J-I, Kobayashi K, Kodera Y, Maeda T, Sato K. Three dimensional structure in solution of the calcium channel blocker ω-conotoxin MVIIA. Biochemistry. 1995;34:10256–65.
Kohno T, Sasaki T, Kobayashi K, Fainzilber M, Sato K. Three-dimensional structure in solution of the sodium channel agonist/antagonist δ-conotoxin TxVIA. J Biol Chem. 2002;277:36387–91.
Kubo S, Chino N, Kimura T, Sakakibara S. Oxidative folding of ω-conotoxin MVIIC: effects of temperature and salt. Biopolymers. 1996;38:733–44.
Lancelin JM, Kohda D, Tate S, Yanagawa Y, Abe T, Satake M, et al. Tertiary structure of conotoxin GIIIA in aqueous solution. Biochemistry. 1991;30:6908–16.
Lee C-W, Lee E-H, Takeuchi K, Takahashi H, Shimada I, Sato K, et al. Molecular basis of the high-affinity activation of type 1 ryanodine receptors by imperatoxin A. Biochem J. 2004;377:385–94.
Lew MJ, Flinn JP, Pallaghy PK, Murphy R, Whorlow SL, Wright CE, et al. Structure-function relationships of ω-conotoxin GVIA. Synthesis, structure, calcium channel binding, and functional assay of alanine-substituted analogues. J Biol Chem. 1997;272:12014–23.
Miljanich GP. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Curr Med Chem. 2004;11:3029–40.
Minami K, Raymond C, Martin-Moutot N, Ohtake A, Renterghem CV, Takahashi M, et al. Role of Thr11 in the binding of ω-conotoxin MVIIC to N-Type Ca2+ channels. FEBS Lett. 2001;491:127–30.
Nakamura H, Kobayashi J, Ohizumi Y, Hirata Y. Isolation and amino acid composition of geographutoxin I and II form the marine snail Conus Geographus. Experientia. 1983;39:590–1.
Nakamura M, Ishida Y, Kohno T, Sato K, Nakamura H. Synthesis of [Cys5]μ-conotoxin GIIIA and its derivatives as a probe of Na+ channel analysis. Biochem Biophys Res Commun. 2001a;283:374–8.
Nakamura M, Niwa Y, Ishida Y, Kohno T, Sato K, Oba Y, et al. Modification of Arg-13 of μ-conotoxin GIIIA with piperidinyl-Arg analogs and their relation to the inhibition of sodium channels. FEBS Lett. 2001b;503:107–10.
Nakamura M, Oba Y, Mori T, Sato K, Ishida Y, Matsuda T, et al. Generation of polyclonal antibody against μ-Conotoxin GIIIA using an immunogen of [Cys5]μ-conotoxin GIIIA site-specifically conjugated with bovine serum albumin. Biochem Biophys Res Commun. 2002;290:1037–41.
Nakamura M, Ishida Y, Kohno T, Sato K, Oba Y, Nakamura H. Effects of modification at the fifth residue of μ-conotoxin GIIIA with bulky tags in the electrically stimulated contraction of the rat diaphragm. J Peptide Res. 2004;64:110–7.
Nemoto N, Kubo S, Yoshida T, Chino N, Kimura T, Sakakibara S, et al. Solution structure of ω-conotoxin MVIIC determined by NMR. Biochem Biophys Res Commun. 1995;207:695–700.
Nielsen KJ, Adams D, Thomas L, Bond T, Alewood PF, Craik DJ, et al. Structure-activity relationships of ω-conotoxins MVIIA, MVIIC and 14 loop splice hybrids at N and P/Q-type calcium channels. J Mol Biol. 1999;289:1405–21.
Nirthanan S, Pil J, Abdel-Mottaleb Y, Sugahara Y, Gopalakrishnakone P, Joseph JS, et al. Assignment of voltage-gated potassium channel blocking activity to κ-KT × 1.3, a non-toxic homologue of κ-hefutoxin-1, from Heterometrus spinifer venom. Biochem Pharmacol. 2005;69:669–78.
Nishiuch Y, Kumagaye K, Noda Y, Watanabe TX, Sakakibara S. Synthesis and secondary-structure determination of ω-conotoxin GVIA: a 27-peptide with three intramolecular disulfide bonds. Biopolymers. 1986;25:S61–8.
Olivera BM, McIntosh JM, Cruz LJ, Luque FA, Gray WR. Purification and sequence of a presynaptic peptide toxin from Conus geographus venom. Biochemistry. 1984;23:5087–90.
Olivera BM, Gray WR, Zeikus R, McIntosh JM, Varga J, Rivier J, et al. Peptide neurotoxins from fish-hunting cone snails. Science. 1985;230:1338–43.
Olivera BM, Cruz LJ, de Santos V, LeCheminant GW, Griffin D, Zeikus R, et al. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using ω-conotoxin from Conus magus venom. Biochemistry. 1987;26:2086–90.
Olivera BM, Rivier J, Clark C, Ramilo CA, Corpuz GP, Abogadie FC, et al. Diversity of Conus neuropeptides. Science. 1990;249:257–63.
Ott K-H, Becker S, Gordon RD, Rüterjans H. Solution structure of μ-conotoxin GIIIA analysed by 2D-NMR and distance geometry calculations. FEBS Lett. 1991;278:160–6.
Pallaghy PK, Norton RS. Refined solution structure of ω-conotoxin GVIA: implications for calcium channel binding. J Pept Res. 1999;53:343–551.
Pallaghy PK, Duggan BM, Pennington MW, Norton RS. Three-dimensional structure in solution of the calcium channel blocker ω-conotoxin. J Mol Biol. 1993;234:405–20.
Peigneur S, Yamaguchi Y, Goto H, Srinivasan KN, Gopalakrishnakone P, Tytgat J, et al. Synthesis and characterization of amino acid deletion analogs of κ-hefutoxin 1, a scorpion toxin on potassium channels. Toxicon. 2013;71:25–30.
Sasaki T, Feng Z-P, Scott R, Grigoriev N, Syed N-I, Fainzilber M, et al. Synthesis, bioactivity and cloning of the L-type calcium channel blocker ω-conotoxin TxVII. Biochemistry. 1999;38:12876–84.
Sasaki T, Kobayashi K, Kohno T, Sato K. Combinatorial synthesis of ω-conotoxin MVIIC analogs and their binding with N and P/Q-type calcium channels. FEBS Lett. 2000;466:125–9.
Sato S, Nakamura H, Ohizumi Y, Kobayashi J, Hirata Y. The amino acid sequences of homologous hydroxyproline-containing myotoxin from the marine snail Conus Geographus venom. FEBS Lett. 1983;155:277–80.
Sato K, Ishida Y, Wakamatsu K, Kato R, Honda H, Ohizumi Y, et al. Active site of μ-conotoxin GIIIA, a peptide blocker of muscle sodium channels. J Biol Chem. 1991;266:16989–91.
Sato K, Park N-G, Kohno T, Maeda T, Kim J-I, Kato R, et al. Role of basic residues for the binding of ω-conotoxin GVIA to N-Type calcium channels. Biochem Biophys Res Commun. 1993;194:1292–6.
Sato K, Raymond C, Martin-Moutot N, Sasaki T, Omori A, Ohtake A, et al. Binding of chimeric analogs of ω-conotoxin MVIIA and MVIIC to the N- and P/Q-type calcium channels. FEBS Lett. 1997;414:480–4.
Sato K, Raymond C, Martin-Moutot N, Sasaki T, Ohtake A, Minami K, et al. Binding of six chimeric analogs of ω-conotoxin MVIIA and MVIIC to N- and P/Q-type calcium channels. Biochem Biophys Res Commun. 2000a;269:254–6.
Sato K, Raymond C, Martin-Moutot N, Sasaki T, Ohtake A, Minami K, et al. Binding of Ala-scanning analogs of ω-conotoxin MVIIC to N- and P/Q-type calcium channels. FEBS Lett. 2000b;469:147–50.
Sato K, Yamaguchi Y, Ishida Y. Roles of individual disulfide bridges in the conformation and activity of μ-conotoxin GIIIA, a peptide blocker of muscle sodium channels. Int J Pept Res Ther. 2014;20:253–8.
Sevilla P, Bruix M, Santoro J, Gago E, Garcia AG, Rico M. Three-dimensional structure of ω-conotoxin GVIA determined by 1H-NMR. Biochem Biophys Res Commum. 1993;192:1238–44.
Skalicky JJ, Metzler WJ, Ciesla DJ, Galdes A, Pardi A. Solution structure of the calcium channel antagonist ω-conotoxin GVIA. Protein Sci. 1993;2:1591–603.
Srinivasan KN, Nirthanan S, Sasaki T, Sato K, Cheng B, Gwee MCE, et al. Functional site of bukatoxin, an α-type sodium channel neurotoxin from the Chinese scorpion (Buthus martensi Karsch) venom: probable role of the 52PDKVP56 loop. FEBS Lett. 2001;494:145–9.
Srinivasan KN, Sivaraja V, Huys I, Sasaki T, Cheng B, Kumar TK, et al. κ-Hefutoxin 1, a novel toxin from the scorpion heterometrus fulvipes with unique structure and function: importance of the functional diad in potassium channel selectivity. J Biol Chem. 2002;277:30040–7.
Tian C, Zhu R, Zhu L, Qiu T, Cao Z, Kang T. Potassium channels: structures, diseases, and modulators. Chem Biol Drug Des. 2014;83:1–26.
Torda AW, Mabbutt BC, van Gunsteren WF, Norton RS. Backbone folding of the polypeptide cardiac stimulant anthopleurin-A determined by nuclear magnetic resonance, distance geometry and molecular dynamics. FEBS Lett. 1988;239:266–70.
Wakamatsu K, Kohda D, Hatanaka H, Lancelin J-M, Ishida Y, Oya M, et al. Structure-activity relationships of μ-conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations. Biochemistry. 1992;31:12577–84.
Williams RJP. NMR studies of mobility within protein structure. Eur J Biochem. 1989;183:479–97.
Zamudio FZ, Gurrola GB, Arevalo C, Sreekumar R, Walker JW, Valdivia HH, et al. Primary structure and synthesis of Imperatoxin A (IpTxa), a peptide activator of Ca2+ release channels/ryanodine receptors. FEBS Lett. 1997;405:385–9.
Zhu S, Peigneur S, Gao B, Luo L, Jin D, Zhao Y, et al. Molecular diversity and functional evolution of scorpion potassium channel toxins. Mol Cell Proteomics. 2011;10(2):M110.002832. doi:10.1074/mcp.M110.002832.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Sato, K. (2017). Synthetic Peptides and Drug Discovery. In: Cruz, L., Luo, S. (eds) Toxins and Drug Discovery. Toxinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6452-1_14
Download citation
DOI: https://doi.org/10.1007/978-94-007-6452-1_14
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6451-4
Online ISBN: 978-94-007-6452-1
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences